Primary ventricular fibrillation: a reason to be cautious

Eur Heart J. 1997 Jun;18(6):890-2. doi: 10.1093/oxfordjournals.eurheartj.a015372.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Clinical Trials as Topic
  • Humans
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / mortality*
  • Prognosis
  • Risk Factors
  • Survival Rate
  • Ventricular Fibrillation / complications
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / mortality*

Substances

  • Anti-Arrhythmia Agents